Blood Screening Market Trends

  • Report ID: 4480
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Blood Screening Market Trends

Growth Drivers

  • Higher Need and Contributions to Blood Donation– As healthcare systems improve and the availability and need for complex surgical operations such as cardiology and transplant surgery, trauma treatment, and therapy for cancer and blood illness increase, so does the demand for donated blood. According to the World Health Organization, every year approximately 119 million units of blood are collected worldwide.
  • Increasing Prevalence of HIV and Hepatitis– By the statistics of the Centers for Disease Control and Prevention, around 296 million people worldwide are living with Hepatitis B. In addition, globally around 38 million people have HIV. HIV testing is necessary for persons who are more likely to catch the virus.
  • Increased Penetration of Malaria- The World Health Organisation (WHO) estimates that there are 300-500 million cases of malaria worldwide each year. Blood screening helps in identifying the Plasmodium species and determining parasitic load in the blood

Challenges

  • Lack of Adequate Infrastructure – Proper equipment, electricity, temperature control, and a hygienic environment are required for the effective screening of blood samples. Apart from that, storage of the samples in the right manner is also necessary.
  • Lack of Skilled Manpower
  • Presence of Alternative Technologies

Blood Screening Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~6%

Base Year Market Size (2022)

~ USD 2,650 Million

Forecast Year Market Size (2035)

~ USD 5,030 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

6.3%

Base Year Market Size (2024)

USD 3 billion

Forecast Year Market Size (2037)

USD 6.54 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4480
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood screening is assessed at USD 3.15 billion.

The blood screening market size was over USD 3 billion in 2024 and is poised to reach USD 6.54 billion by the end of 2037, growing at around 6.3% CAGR during the forecast period i.e., between 2025-2037. Rising number of people suffering with chronic diseases, higher blood transfusions and increased cases of infectious diseases will boost the market growth.

North America is set to be the largest with a industry share of about 38% by 2037, driven by higher demand for blood transfusion in the region.

The major players in the market include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho Clinical Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample